In recent trading session, Compass Therapeutics Inc (NASDAQ:CMPX) saw 0.48 million shares changing hands at last check today with its beta currently measuring 0.61. Company’s recent per share price level of $1.05 trading at $0.0 or 0.00% at last check today assigns it a market valuation of $144.47M. That most recent trading price of CMPX’s stock is at a discount of -186.67% from its 52-week high price of $3.01 and is indicating a premium of 27.62% from its 52-week low price of $0.76. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.32 million shares which gives us an average trading volume of 332.45K if we extend that period to 3-months.
For Compass Therapeutics Inc (CMPX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.43. Splitting up the data highlights that, out of 2 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Compass Therapeutics Inc (NASDAQ:CMPX) trade information
Compass Therapeutics Inc (CMPX) estimates and forecasts
Statistics highlight that Compass Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -27.59% of value to its shares in past 6 months, showing an annual growth rate of -18.18% while that of industry is 15.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.88% during past 5 years.
Compass Therapeutics Inc (NASDAQ:CMPX)’s Major holders
Insiders are in possession of 12.04% of company’s total shares while institution are holding 70.84 percent of that, with stock having share float percentage of 80.54%. Investors also watch the number of corporate investors in a company very closely, which is 70.84% institutions for Compass Therapeutics Inc that are currently holding shares of the company. ORBIMED ADVISORS LLC is the top institutional holder at CMPX for having 22.36 million shares of worth $44.28 million. And as of 2024-03-31, it was holding 17.55 of the company’s outstanding shares.
The second largest institutional holder is ADAGE CAPITAL PARTNERS GP, L.L.C., which was holding about 11.13 million shares on 2024-03-31. The number of shares represents firm’s hold over 8.7346 of outstanding shares, having a total worth of $22.04 million.
